Plus: BioMarin Pharmaceutical to acquire Amicus Therapeutics for $4.8 billion. And the U.S. Navy announces a new warship for President Trump’s “Golden Fleet.” Danny Lewis hosts.

Sign up for WSJ’s free What’s News newsletter.

An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Learn more about your ad choices. Visit megaphone.fm/adchoices